Limits...
MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.

Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K, Hirakawa K, Yasui W - Cancer Sci. (2014)

Bottom Line: In stromal cells, miR-143 enhanced collagen type III expression in normal gastric fibroblasts and cancer-associated fibroblasts through activation of transforming growth factor-β)/SMAD signaling.Furthermore, high miR-143 expression in GC was associated with worse cancer-specific mortality (P = 0.0141).These data suggest that miR-143 regulates fibrosis of scirrhous type GC through induction of collagen expression in stromal fibroblasts and that miR-143 expression serves as a prognostic marker of GC.

View Article: PubMed Central - PubMed

Affiliation: Department of Molecular Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Show MeSH

Related in: MedlinePlus

Effect of transforming growth factor-β (TGF-β) on microRNA-143 (miR-143) and collagen type III expression. (a) Quantitative RT-PCR analysis of miR-143 and collagen type III mRNA in normal gastric fibroblasts (NF-38) and cancer-associated fibroblasts (CaF-38) after the indicated times of TGF-β1 treatment. (b) MicroRNA-143 expression levels in NF-38 and CaF-38 in the absence or presence of TGF-β1 with or without miR-143 inhibitor. (c) Collagen type III mRNA expression levels in NF-38 and CaF-38 in the absence or presence of TGF-β with or without miR-143 inhibitor. (d) Expression levels of TGF-β family signal components were determined by Western blot analysis. (e) Quantitative RT-PCR analysis of miR-143 and collagen type III mRNA in NF-38 and CaF-38 with SMAD4 siRNA. Results are mean ± SE of triplicate measurements. *P < 0.05.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4317817&req=5

fig04: Effect of transforming growth factor-β (TGF-β) on microRNA-143 (miR-143) and collagen type III expression. (a) Quantitative RT-PCR analysis of miR-143 and collagen type III mRNA in normal gastric fibroblasts (NF-38) and cancer-associated fibroblasts (CaF-38) after the indicated times of TGF-β1 treatment. (b) MicroRNA-143 expression levels in NF-38 and CaF-38 in the absence or presence of TGF-β1 with or without miR-143 inhibitor. (c) Collagen type III mRNA expression levels in NF-38 and CaF-38 in the absence or presence of TGF-β with or without miR-143 inhibitor. (d) Expression levels of TGF-β family signal components were determined by Western blot analysis. (e) Quantitative RT-PCR analysis of miR-143 and collagen type III mRNA in NF-38 and CaF-38 with SMAD4 siRNA. Results are mean ± SE of triplicate measurements. *P < 0.05.

Mentions: Scirrhous type GC secretes a larger amount of active form TGF-β than non-scirrhous type GC does,(32) and TGF-β has an important pathological and biological role in scirrhous type GC.(5,7,33,34) To investigate the effect of TGF-β1 on miR-143 and collagen type III expression, NF-38 and CaF-38 were treated with TGF-β1, and their miR-143 expression levels were monitored by qRT-PCR. There were no differences in the expression of endogenous TGF-β1, TGF-β2, or TGF-β3 between NF-38 and CaF-38 (Fig. S2). Treatment with TGF-β1 resulted in strong induction of miR-143 and collagen type III mRNA expression within 96 h in both fibroblasts (Fig. 4a). However, the induction of collagen type III mRNA in fibroblasts by TGF-β1 was significantly suppressed by pretreatment with miR-143 inhibitor (Fig. 4b,c). Interestingly, miR-143 inhibitor significantly suppressed the expression of p-SMAD2 (Fig. 4d), and SMAD4 siRNA significantly downregulated miR-143 and collagen type III mRNA expression in each fibroblast (Fig. 4e). These data imply that miR-143 is deeply involved in the regulation of collagen type III expression by TGF-β/SMAD signaling in NF and CaF.


MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.

Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K, Hirakawa K, Yasui W - Cancer Sci. (2014)

Effect of transforming growth factor-β (TGF-β) on microRNA-143 (miR-143) and collagen type III expression. (a) Quantitative RT-PCR analysis of miR-143 and collagen type III mRNA in normal gastric fibroblasts (NF-38) and cancer-associated fibroblasts (CaF-38) after the indicated times of TGF-β1 treatment. (b) MicroRNA-143 expression levels in NF-38 and CaF-38 in the absence or presence of TGF-β1 with or without miR-143 inhibitor. (c) Collagen type III mRNA expression levels in NF-38 and CaF-38 in the absence or presence of TGF-β with or without miR-143 inhibitor. (d) Expression levels of TGF-β family signal components were determined by Western blot analysis. (e) Quantitative RT-PCR analysis of miR-143 and collagen type III mRNA in NF-38 and CaF-38 with SMAD4 siRNA. Results are mean ± SE of triplicate measurements. *P < 0.05.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4317817&req=5

fig04: Effect of transforming growth factor-β (TGF-β) on microRNA-143 (miR-143) and collagen type III expression. (a) Quantitative RT-PCR analysis of miR-143 and collagen type III mRNA in normal gastric fibroblasts (NF-38) and cancer-associated fibroblasts (CaF-38) after the indicated times of TGF-β1 treatment. (b) MicroRNA-143 expression levels in NF-38 and CaF-38 in the absence or presence of TGF-β1 with or without miR-143 inhibitor. (c) Collagen type III mRNA expression levels in NF-38 and CaF-38 in the absence or presence of TGF-β with or without miR-143 inhibitor. (d) Expression levels of TGF-β family signal components were determined by Western blot analysis. (e) Quantitative RT-PCR analysis of miR-143 and collagen type III mRNA in NF-38 and CaF-38 with SMAD4 siRNA. Results are mean ± SE of triplicate measurements. *P < 0.05.
Mentions: Scirrhous type GC secretes a larger amount of active form TGF-β than non-scirrhous type GC does,(32) and TGF-β has an important pathological and biological role in scirrhous type GC.(5,7,33,34) To investigate the effect of TGF-β1 on miR-143 and collagen type III expression, NF-38 and CaF-38 were treated with TGF-β1, and their miR-143 expression levels were monitored by qRT-PCR. There were no differences in the expression of endogenous TGF-β1, TGF-β2, or TGF-β3 between NF-38 and CaF-38 (Fig. S2). Treatment with TGF-β1 resulted in strong induction of miR-143 and collagen type III mRNA expression within 96 h in both fibroblasts (Fig. 4a). However, the induction of collagen type III mRNA in fibroblasts by TGF-β1 was significantly suppressed by pretreatment with miR-143 inhibitor (Fig. 4b,c). Interestingly, miR-143 inhibitor significantly suppressed the expression of p-SMAD2 (Fig. 4d), and SMAD4 siRNA significantly downregulated miR-143 and collagen type III mRNA expression in each fibroblast (Fig. 4e). These data imply that miR-143 is deeply involved in the regulation of collagen type III expression by TGF-β/SMAD signaling in NF and CaF.

Bottom Line: In stromal cells, miR-143 enhanced collagen type III expression in normal gastric fibroblasts and cancer-associated fibroblasts through activation of transforming growth factor-β)/SMAD signaling.Furthermore, high miR-143 expression in GC was associated with worse cancer-specific mortality (P = 0.0141).These data suggest that miR-143 regulates fibrosis of scirrhous type GC through induction of collagen expression in stromal fibroblasts and that miR-143 expression serves as a prognostic marker of GC.

View Article: PubMed Central - PubMed

Affiliation: Department of Molecular Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Show MeSH
Related in: MedlinePlus